4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000899243-22-030087
Chief Financial Officer sold 6,017 shares at $0.89 ($5,378)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sath Chief Financial Officer | 2022-08-29 | Sale | −6,017 | $0.89 | $5,378 | 56,064 | D |
| Open-market sales · 6,017 sh · avg $0.89 · $5,378 | |||||||
Loading xslF345X03/doc4.xml…